生命科学资讯

Gene editing pioneers launch first startup focused on custom CRISPR therapies

Aurora sets out to capitalize on FDA’s new framework for bespoke drug therapies

Roche returns to MediLink with $570M near-term payments for ADC - Fierce Biotech

Robeco Institutional Asset Management B.V. Acquires 26,573 Shares of Agilent Technologies, Inc. $A - MarketBeat

Stifel raises Thermo Fisher Scientific stock price target to $700 on biopharma growth outlook - Investing.com

Stifel raises Thermo Fisher Scientific stock price target to $700 on biopharma growth outlook - Investing.com India

Illumina hires former NHGRI director Eric Green as new chief medical officer - Fierce Biotech

Agilent Technologies: Why Execution Matters Most When the Cycle Turns - Investing.com

Agilent Technologies: Why Execution Matters Most When the Cycle Turns - Investing.com

Illumina and PREMIA partner to expand clinical access to CGP in Asia - TheWire.in

Why Waters Corporation stock remains on buy lists - Chart Signals & Low Risk Entry Point Tips - ulpravda.ru

Aktis lands biotech's first IPO of 2026, raising $318M for radiopharmaceuticals

Aktis raises $318M in 2026’s first biotech IPO

OpenAI brings ChatGPT to hospitals on the heels of launching consumer health tool

Why Waters Corporation stock remains on buy lists - Global Markets & Precise Buy Zone Identification - ulpravda.ru

Assessing 10x Genomics (TXG) Valuation After Recent Share Price Momentum Shift - Yahoo Finance

Ollin eyes phase 3 after bispecific tops Vabysmo in early-stage trial, clearing more retinal disease faster

The interplay between biomolecular assembly and phase separation

Affinity-guided labeling reveals P2X7 nanoscale membrane redistribution during BV2 microglial activation

Short activation domains control chromatin association of transcription factors